
FDA Clears FIRST Alzheimer’s Blood Test
New Test Provides Less Invasive Option, Reduces Reliance on PET Scans and Increases Diagnosis Accessibility
New Test Provides Less Invasive Option, Reduces Reliance on PET Scans and Increases Diagnosis Accessibility
DOES AGE LEAD to deterioration of brain function, or do older brains just take longer to process ever increasing amounts of knowledge? The latest research may surprise you.
P-tau217 is a blood-based marker for Alzheimer’s. See how it offers a simpler, cheaper way to analyze Alzheimer’s.
Why can vision loss come before memory loss in 10% of Alzheimer’s? A new study shows Posterior Cortical Atrophy (PCA), a type of Alzheimer’s, distributes proteins differently.
Twenty percent of people over 65 have mild memory and thinking problems that don’t interfere with day-to-day life. Doctors call this MCI, short for Mild Cognitive Impairment. Find out more about what it is and what to do about it.
A fascinating Smell-Test developed at Mass General Brigham may help determine your risk of developing Alzheimer’s.
Teepa Snow, Dementia Care Specialist, shares what you need to know about conditions that can mimic dementia, but are actually reversible or treatable.
DIAGNOSIS VIDEO: TEEPA SNOW explores the challenge of getting a good diagnosis in today’s medical system. See her explain differences between Alzheimer’s and other dementias. Learn how to prepare for a brain health checkup.
The Founder and CEO of The Brainwell Institute shares the deep understanding of cognitive function that’s needed for a good diagnosis of dementia. Learn what you need to know, in plain English.
(Video & Article) L.A.T.E. Dementia is frequently misdiagnosed as Alzheimer’s. That’s why, in January 2025, researchers created new guidelines. It affects millions of people, approximately 40% of people over 80. How is it recognized? What makes it different?
VIDEO + ARTICLE: Residential areas with more green space were associated with faster thinking, better attention, and higher overall cognitive function in a federal study. Learn more.
Lecanemab is today’s #1 Alzheimer’s antibody. (Brand name: Leqembi) Washington University researchers found Lecanemab’s adverse events to be rare and manageable in very mild or mild Alzheimer’s.
Alzheimer’s is characterized by an overproduction of free radicals in cells. That’s why incredibly tiny “nanoparticles” of silver, found in supplements, cosmetics and food packaging, worry scientists. Hear their concerns, as well as products to avoid.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.